Results 101 to 108 of about 581 (108)

Analytical and Bioanalytical HPLC Method for Simultaneous estimation of 5-Fluorouracil and Sonidegib

Bioanalysis, 2022
Dr Aswathi R Hegde, Srinivas Mutalik, Swati Biswas   +2 more
exaly  

Improving the Antitumor Activity and Bioavailability of Sonidegib for the Treatment of Skin Cancer

Pharmaceutics, 2021
Amr Gamal F, Haitham Saeed, Fatma I Abo El-Ela   +2 more
exaly  

Smoothened antagonist sonidegib affects the development of larvae via suppression of epidermis formation

Pesticide Biochemistry and Physiology, 2023
Gaofeng Cui, Zhi-Yan Jiang, Guohua Zhong
exaly  

Sonidegib for the Treatment of Advanced Basal Cell Carcinoma: A Comprehensive Review of Sonidegib and the Bolt Trial with 12-Month Update

Future Oncology, 2016
Michael R Migden
exaly  

Effect of esomeprazole, a proton pump inhibitor on the pharmacokinetics of sonidegib in healthy volunteers

British Journal of Clinical Pharmacology, 2016
Franck Picard, Jocelyn Zhou
exaly  

A phase Ib study of sonidegib (LDE225), an oral small molecule inhibitor of smoothened or Hedgehog pathway, in combination with docetaxel in triple negative advanced breast cancer patients: GEICAM/2012–12 (EDALINE) study

Investigational New Drugs, 2018
Jose A Garcia-Saenz, Miguel Martin, Helena Colom   +2 more
exaly  

Population pharmacokinetics of sonidegib (LDE225), an oral inhibitor of hedgehog pathway signaling, in healthy subjects and in patients with advanced solid tumors

Cancer Chemotherapy and Pharmacology, 2016
Andrew M Stein, Sven Gogov, Jocelyn Zhou
exaly  

The 12-month analysis from Basal Cell Carcinoma Outcomes with LDE225 Treatment (BOLT): A phase II, randomized, double-blind study of sonidegib in patients with advanced basal cell carcinoma

Journal of the American Academy of Dermatology, 2016
Ralf Gutzmer, Ragini R Kudchadkar, Reinhard Dummer   +2 more
exaly